Results 231 to 240 of about 605,792 (294)
Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108 [PDF]
Abi-Chaker, Andrew +8 more
core
Synthesis and cell cancer growth inhibiting properties of somatostatin analogs
Jolanta Dyniewicz +2 more
openalex +1 more source
A new era in oral treatment for acromegaly with the FDA-approved drug paltusotine. [PDF]
Ahmed S, Asghar H, Khalid M.
europepmc +1 more source
Osteoporosis and fragility fractures in patients with acromegaly: A two-center cross-sectional study. [PDF]
Alvarez M +7 more
europepmc +1 more source
Acromegaly: Treatment with somatostatin analogs
Karavitaki, N, Wass, J
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Drug Targets, 2016
Somatostatin (SST) is a cyclic hormone-release inhibitory peptide that has high binding affinity to all of its five SST receptors (SSTRs). SST negatively regulates cell proliferation and the release of multiple hormones via activation of its cognate receptors.
Lichun, Sun, David H, Coy
openaire +3 more sources
Somatostatin (SST) is a cyclic hormone-release inhibitory peptide that has high binding affinity to all of its five SST receptors (SSTRs). SST negatively regulates cell proliferation and the release of multiple hormones via activation of its cognate receptors.
Lichun, Sun, David H, Coy
openaire +3 more sources
Current Molecular Medicine, 2013
The pharmacological effects (i.e., inhibition of endocrine secretion and cell proliferation) mediated by the hormone somatostatin (SRIF) are derived from its universal high-affinity binding to five different G proteincoupled receptors (GPCRs), named sst1-5.
Ruscica M +4 more
openaire +5 more sources
The pharmacological effects (i.e., inhibition of endocrine secretion and cell proliferation) mediated by the hormone somatostatin (SRIF) are derived from its universal high-affinity binding to five different G proteincoupled receptors (GPCRs), named sst1-5.
Ruscica M +4 more
openaire +5 more sources
The Journal of Peptide Research, 2001
Abstract: Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin, and also plays a role in neural transmission. Because of its wide range of possible clinical applications hundreds of somatostatin analogs have been synthesized and bioassayed to date.
A, Janecka, M, Zubrzycka, T, Janecki
openaire +2 more sources
Abstract: Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin, and also plays a role in neural transmission. Because of its wide range of possible clinical applications hundreds of somatostatin analogs have been synthesized and bioassayed to date.
A, Janecka, M, Zubrzycka, T, Janecki
openaire +2 more sources

